Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(5), P. 2911 - 2911
Published: March 2, 2024
This
paper
delves
into
the
diverse
and
significant
roles
of
curcumin,
a
polyphenolic
compound
from
Curcuma
longa
plant,
in
context
cancer
inflammatory
diseases.
Distinguished
by
its
unique
molecular
structure,
curcumin
exhibits
potent
biological
activities
including
anti-inflammatory,
antioxidant,
potential
anticancer
effects.
The
research
comprehensively
investigates
curcumin’s
interactions
with
key
proteins
involved
progression
response,
primarily
through
docking
studies.
In
cancer,
effectiveness
is
determined
examining
interaction
pivotal
like
CDK2,
CK2α,
GSK3β,
DYRK2,
EGFR,
among
others.
These
suggest
role
impeding
cell
proliferation
survival.
Additionally,
highlights
impact
on
inflammation
influence
such
as
COX-2,
CRP,
PDE4,
MD-2,
which
are
central
to
pathway.
vitro
clinical
studies
extensively
reviewed,
shedding
light
binding
mechanisms,
pharmacological
impacts,
therapeutic
application
various
cancers
conditions.
understanding
functionality
agent.
Conclusively,
this
review
emphasizes
promise
treating
wide
range
health
issues,
attributed
complex
chemistry
broad
properties.
points
towards
growing
importance
multi-faceted
natural
medical
scientific
community.
Language: Английский
Molecular and phylogenetic characterization of the monkeypox outbreak in the South of Spain
Health Science Reports,
Journal Year:
2024,
Volume and Issue:
7(3)
Published: March 1, 2024
Abstract
Background
and
Aim
Until
the
May
2022
Monkeypox
(MPXV)
outbreak,
which
spread
rapidly
to
many
non‐endemic
countries,
virus
was
considered
a
viral
zoonosis
limited
some
African
countries.
The
Andalusian
circuit
of
genomic
surveillance
applied
characterize
MPXV
outbreak
in
South
Spain.
Methods
Whole
genome
sequencing
used
obtain
profiles
samples
collected
across
south
Spain,
representative
all
provinces
Andalusia.
Phylogenetic
analysis
study
relationship
isolates
available
sequences
outbreak.
Results
total
160
viruses
from
different
that
reported
cases
were
obtained.
Interestingly,
we
report
obtained
two
patients
who
died.
While
one
bore
no
noteworthy
mutations
explain
potential
heightened
virulence,
another
patient
second
consecutive
sequence,
performed
after
administration
tecovirimat,
uncovered
mutation
within
A0A7H0DN30
gene,
known
be
prime
target
for
tecovirimat
its
Vaccinia
counterpart.
In
general,
low
number
observed
reported,
very
similar
reference
(OX044336),
as
expected
DNA
virus.
likely
correspond
several
introductions
circulating
last
sequenced
died
presented
gene
bears
connections
drug
resistance.
This
absent
initial
before
treatment.
Language: Английский
Structural and pharmacological insights into cordycepin for neoplasms and metabolic disorders
Jinming Zhang,
No information about this author
Ziling Yang,
No information about this author
Zhuo Zhao
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: June 17, 2024
Cytotoxic
adenosine
analogues
were
among
the
earliest
chemotherapeutic
agents
utilised
in
cancer
treatment.
Cordycepin,
a
natural
derivative
of
discovered
fungus
Ophiocordyceps
sinensis,
directly
inhibits
tumours
not
only
by
impeding
biosynthesis,
inducing
apoptosis
or
autophagy,
regulating
cell
cycle,
and
curtailing
tumour
invasion
metastasis
but
also
modulates
immune
response
within
microenvironment.
Furthermore,
extensive
research
highlights
cordycepin’s
significant
therapeutic
potential
alleviating
hyperlipidaemia
glucose
metabolism.
This
review
comprehensively
analyses
structure-activity
relationship
cordycepin
its
analogues,
outlines
pharmacokinetic
properties,
strategies
to
enhance
bioavailability.
Delving
into
molecular
biology,
it
explores
pharmacological
mechanisms
suppression
metabolic
disorder
treatment,
thereby
underscoring
immense
drug
development
these
domains
laying
groundwork
for
innovative
treatment
strategies.
Language: Английский